枸橼酸抗凝在血液透析高危出血患者中的应用

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of citrate anticoagulation in hemodialysis patients with high-risk hemorrhage.Methods From October to December in 2017,80 maintenance hemodialysis(HD)patients complicated with hemorrhage bleeding tendency treated in our hospital were selected as the subject,and randomly divided into two groups,40 cases each group.The control group took the heparin-free hemodialysis.The observation group took the 4%citrate anticoagulation.The coagulation condition and biochemical indicators as well as the index of Kt/V,URR,APTT and actual ultrafiltration capacity were evaluated.Results The hemodialysis in idalyzer in the observation group was significantly better than that in the control group,the difference was statistically significant(P＜0.05).After HD,the index of BUN and SCr in the observation group were even lower than that in the control group,the difference was statistically significant(P＜0.05).Before and after HD,the value of PH,Ca2+and K+for two groups were not significantly different(P＞0.05).The value of HCO3-in the observation group was significantly higher than that in the control group,the difference was statistically significant(P＜0.05).The index of KT/V and URR for two groups were not significantly different(P＞0.05).The index of APTT in the observation group was significantly lower than that in the control group,the difference was statistically significant(P＜0.05).The actual ultrafiltration capacity in the observation group was significantly higher than,it has the value of promotion control group,the difference was statistically significant(P＜0.05).Conclusion For HD patients with high-risk hemorrhage,the citrate anticoagulation can improve the clinical safety and effect.In addition,the hemodialysis effect is not affected,it has the value of promotion.

Key words： High-risk hemorrhage Citrate anticoagulation Hemodialysis Application effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	PANG Juan

Cite this article:

PANG Juan. Application of citrate anticoagulation in hemodialysis patients with highrisk hemorrhage[J]. 中国当代医药, 2018, 25(14): 38-40转44.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I14/38

[1]	张东亮，张潘，张周沧，等.分段枸橼酸抗凝进行含钙透析液高通量血液透析的临床观察[J].中国血液净化，2016，15（12）：686-690.
[2]	朱文芳，何建强，巢军，等.枸橼酸、无肝素和低分子肝素抗凝在血液透析中的应用评价[J].临床医学，2015，35（5）：39-41.
[3]	郭丹林，蓝怡婷，庄兆红，等.持续缓慢低效血液透析应用枸橼酸抗凝的临床护理配合[J].首都食品与医药，2015，22（10）：96-97.
[4]	杨松涛，赵娜，胡军，等.应用普通含钙透析液局部枸橼酸抗凝血液透析的临床观察[J].中国血液净化，2017，16（7）：474-476，487.
[5]	丁利.尿毒症并发出血患者应用枸橼酸抗凝的护理体会[J].世界临床医学，2016，10（18）：182.
[6]	赵敬娜，刘艳琴，曹月杰，等.ANCA相关血管炎肾衰竭患者在以局部枸橼酸抗凝进行血浆置换中发生低钙血症的处理[J].中国血液净化，2016，15（4）：256.
[7]	覃莲香，王艺萍，吴虹，等.难治性继发性甲状旁腺功能亢进患者甲状旁腺切除术围术期应用枸橼酸钠抗凝的临床观察[J].北京医学，2017，39（3）：266-270.
[8]	李玲，倪春燕.脑干出血伴急性肾衰竭1例床旁血液净化枸橼酸抗凝治疗及临床护理[J].齐鲁护理杂志，2016，22（3）：94-95.
[9]	高建平，王峰，王勇刚，等.RCA-CRRT在高出血风险急性肾损伤患者中的初步研究[J].中华急诊医学杂志，2017，26（9）：1020-1026.
[10]	徐志坚，李桂兰，林瑛，等.低浓度枸橼酸盐局部抗凝技术对改善高危出血倾向行CRRT治疗的疗效分析[J].浙江临床医学，2016，18（8）：1432-1433，1440.
[11]	王侃，王迎，黄心洁，等.局部枸橼酸抗凝在体外循环术后连续性肾脏替代治疗的应用[J].重庆医学，2017，46（1）：106-108.
[12]	朱淑华，樊蓉，徐斌，等.简化枸橼酸抗凝无肝素透析的疗效观察[J].肾脏病与透析肾移植杂志，2017，26（4）：323-327.
[13]	屈靖，叶飞，王文力，等.体外局部枸橼酸抗凝在改良床旁血液滤过中的应用[J].内科急危重症杂志，2015，21（1）：56-57.
[14]	袁瑞，帅维正，张志成，等.肝素与枸橼酸抗凝在海水浸泡低体温症犬连续血液滤过复温中的对比研究[J].中国当代医药，2017，24（24）：4-6，10.
[15]	武子霞，穆恩，翁欣，等.局部枸橼酸抗凝在重症创伤患者连续性静脉-静脉血液滤过中的应用[J].中国中西医结合急救杂志，2016，23（3）：307-309.